It comes in a pre-filled pen that patients can administer subcutaneously (under the skin)
This change has opened doors for millions who previously found medical weight loss programs inaccessible due to cost, distance, or time constraints
If millions of people are covered, it could increase premiums going forward. Cubanski said even a few dollars in higher premiums can be a big deal for people on Medicare who often are retired and have limited incomes
Preclinical work demonstrates incretin receptor gene and protein expression in female reproductive tissues such as ovary and uterine structures in animal models, supporting the concept that incretin signalling can interact with reproductive physiologyagain, not equivalent to a clinically meaningful direct vaginal mucosal effect in humans
At this time, only Wegovy is approved for weight loss in children 12 years and older
This decision was based on data suggesting that manufacturers could now meet the current and projected demand for injectable semaglutide, the active ingredient in popular medications like Ozempic and Wegovy
